Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caffeine induces central cholinergic analgesia

C Ghelardini1, N Galeotti, A Bartolini

  • 1Department of Preclinical and Clinical Pharmacology, Florence, Italy.

Naunyn-Schmiedeberg'S Archives of Pharmacology
|December 24, 1997
PubMed
Summary

Caffeine demonstrates pain-relieving effects in mice and rats, acting through a central cholinergic pathway. This study reveals caffeine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potent and selective adenosine A<sub>2A</sub>R antagonists P400 and P625 protect against symptoms in autoimmune experimental encephalomyelitis by attenuating neuroinflammation and demyelination.

Neuropharmacology·2026
Same author

Protection From Demyelination by the Novel Adenosine Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonist P626 in EAE and Cultured Oligodendrocyte Precursor Cells.

Journal of cellular and molecular medicine·2025
Same author

The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effects.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

Retraction of "Acetyl-l-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy" [Neuroscience 167(4) (2010) 1168-1174].

Neuroscience·2024
Same author

Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease.

Gut microbes·2023
Same author

Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H<sub>2</sub>S-donor Erucin against ischemia/reperfusion injury.

Biochemical pharmacology·2023

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Research

Background:

  • Caffeine is a widely consumed stimulant.
  • Its potential pain-relieving (antinociceptive) properties require further investigation.
  • Understanding caffeine's mechanism of action is crucial for its therapeutic applications.

Purpose of the Study:

  • To investigate the antinociceptive effects of caffeine in rodent models.
  • To elucidate the neurochemical pathways involved in caffeine-induced analgesia.
  • To assess caffeine's safety profile at effective antinociceptive doses.

Main Methods:

  • Utilized hot-plate, abdominal constriction, tail flick, and paw-pressure tests in mice and rats.
  • Administered caffeine via subcutaneous (s.c.) and intraperitoneal (i.p.) routes, as well as intracerebroventricular (i.c.v.) injection.
  • Tested the involvement of cholinergic, opioid, and other neurotransmitter systems using specific antagonists and inhibitors.

Main Results:

  • Caffeine produced significant antinociception in both mice and rats.
  • The effect was blocked by cholinergic antagonists (atropine, pirenzepine) and agents affecting central cholinergic transmission (hemicholinium-3, N6-cyclopentyladenosine).
  • Opioid (naloxone) and other neurotransmitter system modulators did not affect caffeine's antinociception.
  • Intracerebroventricular caffeine induced analgesia without behavioral impairment.

Conclusions:

  • Caffeine exerts a centrally mediated antinociceptive effect.
  • The mechanism involves the amplification of central cholinergic transmission.
  • Caffeine is a potential analgesic agent with a favorable safety profile at effective doses.

Related Experiment Videos